Lpl Financial LLC Lineage Cell Therapeutics, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 30,734 shares of LCTX stock, worth $15,367. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,734

Previous 31,519 2.49%

Holding current value

$15,367

Previous $31,000 12.9%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$0.8 - $1.12 $628 - $879	-785 Reduced 2.49%	30,734 $27,000
Q2 2024 Aug 07, 2024	SELL	$0.89 - $1.47 $8,896 - $14,694	-9,996 Reduced 24.08%	31,519 $31,000
Q1 2024 May 10, 2024	SELL	$0.86 - $1.48 $33,969 - $58,458	-39,499 Reduced 48.76%	41,515 $61,000
Q4 2023 Feb 14, 2024	SELL	$0.91 - $1.35 $13,637 - $20,231	-14,986 Reduced 15.61%	81,014 $88,000
Q3 2023 Nov 13, 2023	SELL	$1.16 - $1.53 $23,200 - $30,600	-20,000 Reduced 17.24%	96,000 $113,000
Q2 2023 Jul 31, 2023	SELL	$1.26 - $1.53 $17,691 - $21,482	-14,041 Reduced 10.8%	116,000 $163,000
Q1 2023 May 10, 2023	SELL	$1.2 - $1.53 $24,616 - $31,386	-20,514 Reduced 13.63%	130,041 $195,000
Q4 2022 Feb 07, 2023	SELL	$1.02 - $1.5 $39,540 - $58,147	-38,765 Reduced 20.48%	150,555 $176,000
Q3 2022 Nov 14, 2022	SELL	$1.13 - $1.77 $56,499 - $88,500	-50,000 Reduced 20.89%	189,320 $214,000
Q2 2022 Aug 12, 2022	BUY	$1.12 - $1.61 $92,388 - $132,808	82,490 Added 52.6%	239,320 $378,000
Q1 2022 May 16, 2022	BUY	$1.21 - $2.48 $56,917 - $116,656	47,039 Added 42.84%	156,830 $242,000
Q4 2021 Feb 14, 2022	BUY	$1.84 - $2.68 $40,868 - $59,525	22,211 Added 25.36%	109,791 $269,000
Q3 2021 Nov 15, 2021	BUY	$2.26 - $2.86 $61,471 - $77,792	27,200 Added 45.05%	87,580 $221,000
Q2 2021 Aug 13, 2021	BUY	$2.17 - $3.0 $27,658 - $38,238	12,746 Added 26.76%	60,380 $172,000
Q1 2021 May 14, 2021	BUY	$1.77 - $3.1 $39,932 - $69,939	22,561 Added 89.98%	47,634 $112,000
Q4 2020 Feb 12, 2021	BUY	$0.95 - $1.83 $963 - $1,855	1,014 Added 4.21%	25,073 $44,000
Q3 2020 Nov 09, 2020	SELL	$0.75 - $1.09 $1,192 - $1,733	-1,590 Reduced 6.2%	24,059 $23,000
Q2 2020 Aug 13, 2020	BUY	$0.71 - $1.18 $7,117 - $11,828	10,024 Added 64.15%	25,649 $22,000
Q1 2020 May 14, 2020	SELL	$0.6 - $1.58 $1,013 - $2,668	-1,689 Reduced 9.76%	15,625 $13,000
Q4 2019 Feb 14, 2020	SELL	$0.54 - $1.01 $209 - $391	-388 Reduced 2.19%	17,314 $15,000
Q3 2019 Nov 13, 2019	BUY	$0.85 - $1.24 $15,046 - $21,950	17,702 New	17,702 $17,000

Others Institutions Holding LCTX

# of Institutions

121

Shares Held

94.2M

Call Options Held

63.8K

Put Options Held

View Full List

About Lineage Cell Therapeutics, Inc.

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $84.9M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

More about LCTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Lineage Cell Therapeutics, Inc. Transaction History